Descriptor English: | Vemurafenib | ||||||
Descriptor Spanish: |
Vemurafenib
| ||||||
Descriptor Portuguese: | Vemurafenib | ||||||
Descriptor French: | Vémurafénib | ||||||
Entry term(s): |
PLX 4032 PLX4032 R05185426 RG 7204 RG-7204 RG7204 Zelboraf |
||||||
Tree number(s): |
D02.065.884.919 D02.886.590.700.919 D03.633.100.473.936 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077484 | ||||||
Scope note: | An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents Protein Kinase Inhibitors |
||||||
Registry Number: | 207SMY3FQT | ||||||
CAS Type 1 Name: | 1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)- | ||||||
Public MeSH Note: | 2019; VEMURAFENIB was indexed under INDOLES and SULFONAMIDES 2010-2018 |
||||||
History Note: | 2019 (2010) |
||||||
DeCS ID: | 57657 | ||||||
Unique ID: | D000077484 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/09 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Vemurafenib
- Preferred
PLX4032
- Narrower
RG7204
- Narrower
Zelboraf
- Narrower
R05185426
- Narrower
Concept UI |
M0558887 |
Scope note | An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA. |
Preferred term | Vemurafenib |
Concept UI |
M0548744 |
Preferred term | PLX4032 |
Entry term(s) |
PLX 4032 |
Concept UI |
M000623499 |
Preferred term | RG7204 |
Entry term(s) |
RG 7204 RG-7204 |
Concept UI |
M0574188 |
Preferred term | Zelboraf |
Concept UI |
M000623498 |
Preferred term | R05185426 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey